135 related articles for article (PubMed ID: 29486265)
1. Design of cellulose ether-based macromolecular prodrugs of ciprofloxacin for extended release and enhanced bioavailability.
Amin M; Abbas NS; Hussain MA; Sher M; Edgar KJ
Int J Biol Macromol; 2018 Jul; 113():719-728. PubMed ID: 29486265
[TBL] [Abstract][Full Text] [Related]
2. Extended release and enhanced bioavailability of moxifloxacin conjugated with hydrophilic cellulose ethers.
Abbas NS; Amin M; Hussain MA; Edgar KJ; Tahir MN; Tremel W
Carbohydr Polym; 2016 Jan; 136():1297-306. PubMed ID: 26572474
[TBL] [Abstract][Full Text] [Related]
3. Designing novel bioconjugates of hydroxyethyl cellulose and salicylates for potential pharmaceutical and pharmacological applications.
Abbas K; Amin M; Hussain MA; Sher M; Bukhari SNA; Jantan I; Edgar KJ
Int J Biol Macromol; 2017 Oct; 103():441-450. PubMed ID: 28526350
[TBL] [Abstract][Full Text] [Related]
4. A novel gel based on an ionic complex from a dendronized polymer and ciprofloxacin: Evaluation of its use for controlled topical drug release.
García MC; Cuggino JC; Rosset CI; Páez PL; Strumia MC; Manzo RH; Alovero FL; Alvarez Igarzabal CI; Jimenez-Kairuz AF
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():236-46. PubMed ID: 27612709
[TBL] [Abstract][Full Text] [Related]
5. Functionalized phosphorylated cellulose microspheres: Design, characterization and ciprofloxacin loading and releasing properties.
Wu S; Gong Y; Liu S; Pei Y; Luo X
Carbohydr Polym; 2021 Feb; 254():117421. PubMed ID: 33357902
[TBL] [Abstract][Full Text] [Related]
6. Hydroxypropylcellulose-flurbiprofen conjugates: design, characterization, anti-inflammatory activity and enhanced bioavailability.
Hussain MA; Shad I; Malik I; Amjad F; Kausar T; Kamran ; Sher M; Tahir MN; Ullah N; Ashraf M; Bukhari SNA
Saudi Pharm J; 2020 Jul; 28(7):869-875. PubMed ID: 32647489
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices.
Sinha Roy D; Rohera BD
Eur J Pharm Sci; 2002 Aug; 16(3):193-9. PubMed ID: 12128174
[TBL] [Abstract][Full Text] [Related]
8. Studies of ciprofloxacin encapsulation on alginate/pectin matrixes and its relationship with biodisponibility.
Islan GA; de Verti IP; Marchetti SG; Castro GR
Appl Biochem Biotechnol; 2012 Jul; 167(5):1408-20. PubMed ID: 22371066
[TBL] [Abstract][Full Text] [Related]
9. Preparation, degradation and in vitro release of ciprofloxacin-eluting ureteral stents for potential antibacterial application.
Ma X; Xiao Y; Xu H; Lei K; Lang M
Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():92-99. PubMed ID: 27207042
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of carboxymethylated nanocellulose fabricated ciprofloxacine - Montmorillonite composite for sustained delivery of antibiotics.
Hong HJ; Kim J; Kim DY; Kang I; Kang HK; Ryu BG
Int J Pharm; 2019 Aug; 567():118502. PubMed ID: 31295525
[TBL] [Abstract][Full Text] [Related]
12. Dual acting acid-cleavable self-assembling prodrug from hyaluronic acid and ciprofloxacin: A potential system for simultaneously targeting bacterial infections and cancer.
Ibrahim UH; Devnarain N; Mohammed M; Omolo CA; Gafar MA; Salih M; Pant A; Shunmugam L; Mocktar C; Khan R; Oh JK; Govender T
Int J Biol Macromol; 2022 Dec; 222(Pt A):546-561. PubMed ID: 36150574
[TBL] [Abstract][Full Text] [Related]
13. Preparation of ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) microspheres and its antibacterial activity.
Jeong YI; Na HS; Nah JW; Lee HC
J Pharm Sci; 2009 Oct; 98(10):3659-65. PubMed ID: 19226632
[TBL] [Abstract][Full Text] [Related]
14. Pulse release of doxazosin from hydroxyethylcellulose compression coated tablet: mechanistic and in vivo study.
Biswas N; Guha A; Sahoo RK; Kuotsu K
Int J Biol Macromol; 2015 Jan; 72():537-43. PubMed ID: 25179280
[TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment.
Shazly GA
Biomed Res Int; 2017; 2017():2120734. PubMed ID: 28194408
[TBL] [Abstract][Full Text] [Related]
16. Poly(HEMA-Zidovudine) conjugate: a macromolecular pro-drug for improvement in the biopharmaceutical properties of the drug.
Neeraj A; Chandrasekar MJ; Sara UV; Rohini A
Drug Deliv; 2011 May; 18(4):272-80. PubMed ID: 21110710
[TBL] [Abstract][Full Text] [Related]
17. Insights into the Kinetics of the Resistance Formation of Bacteria against Ciprofloxacin Poly(2-methyl-2-oxazoline) Conjugates.
Schmidt M; Romanovska A; Wolf Y; Nguyen TD; Krupp A; Tumbrink HL; Lategahn J; Volmer J; Rauh D; Luetz S; Krumm C; Tiller JC
Bioconjug Chem; 2018 Aug; 29(8):2671-2678. PubMed ID: 29927244
[TBL] [Abstract][Full Text] [Related]
18. Three-in-One Peptide Prodrug with Targeting, Assembly and Release Properties for Overcoming Bacterium-Induced Drug Resistance and Potentiating Anti-Cancer Immune Response.
Gao G; Jiang YW; Chen J; Xu X; Sun X; Xu H; Liang G; Liu X; Zhan W; Wang M; Xu Y; Zheng J; Wang G
Adv Mater; 2024 Jun; 36(23):e2312153. PubMed ID: 38444205
[TBL] [Abstract][Full Text] [Related]
19. Development of poly(vinyl alcohol) porous scaffold with high strength and well ciprofloxacin release efficiency.
Zhou XH; Wei DX; Ye HM; Zhang X; Meng X; Zhou Q
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():326-335. PubMed ID: 27287128
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureus.
Ahire JJ; Neveling DP; Hattingh M; Dicks LM
PLoS One; 2015; 10(4):e0123648. PubMed ID: 25853255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
